Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios Pro Rata

Dive into the world of dealmakers across VC, PE and M&A with Axios Pro Rata. Delivered daily to your inbox by Dan Primack and Kia Kokalitcheva.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Austin news?

Get a daily digest of the most important stories affecting your hometown with the Axios Austin newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Atlanta news?

Get a daily digest of the most important stories affecting your hometown with the Axios Atlanta newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Philadelphia news?

Get a daily digest of the most important stories affecting your hometown with the Axios Philadelphia newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Chicago news?

Get a daily digest of the most important stories affecting your hometown with the Axios Chicago newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top DC news?

Get a daily digest of the most important stories affecting your hometown with the Axios DC newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Photo: Richard Baker / In Pictures via Getty Images

68 people have died from a lung injury associated with e-cigarette use in 29 states and the District of Columbia, the Centers for Disease Control and Prevention reports as of Feb. 18.

What's new: Because of the consistent declines in new EVALI cases since Sept. 2019, as well as the identification of vitamin E acetate as a primary cause of EVALI, Tuesday's report will be the final CDC update on the number of hospitalized EVALI cases and deaths nationally.

CDC explains the steady drop in cases as likely multifactorial and possibly related to:

  • Public awareness of the risk associated with THC-containing e-cigarettes, vaping and product use.
  • The elimination of vitamin E acetate from some products.
  • Law enforcement response related to illicit products.

Details: CDC, FDA and individual state health officials "have made progress in identifying the cause of EVALI," CDC reports.

  • Nationally, most vaping-related patients with data on how they sourced products reported obtaining THC-containing products from "informal sources," per the CDC. The agency recommends users should consider no longer vaping THC products, rather than its original claim to refrain from e-cigarettes.
  • Vitamin E acetate has been found in product samples tested by FDA and state labs and patient lung fluid samples tested by CDC across the country.
  • Vitamin E acetate is not present in the lung fluid of those who do not have EVALI.
  • Based on several studies, federal health officials found in late 2019 vitamin E acetate in a sample of illicit products in select states and the additive also caused lung fluid in 48 patients out of 51 diagnosed with the vaping illness.

By the numbers: Data as of Feb. 18 showed the median age of patients who died was 49.5 years old and the ages of those who died ranged from 15 to 75.

The impact: The CDC and states' individual health departments have data on where EVALI-related deaths occurred:

  • The Henry Ford Hospital in Detroit announced in mid-November that a 17-year-old boy faced "imminent death" from vaping injuries unless he underwent a double lung transplant. It was the first transplant performed on a patient with the vaping-related illness.
  • In New York, the first teenager died after being hospitalized twice in September with a vaping-related illness.
  • In Massachusetts, the death of a woman in her 60s was reported on Oct. 7 as the state's first vaping-related death. The state currently has a four-month ban on all vaping products, the harshest in the U.S.
  • In Georgia, a patient with a history of heavy nicotine vaping, but no reported background of vaping THC, died, Georgia's Department of Health said.
  • A man and woman in Kansas, both over the age of 50 with "underlying health conditions," died from a pulmonary illness linked to vaping, according to Kansas Gov. Laura Kelly.
  • A Missouri man in his mid-40s died from the illness, according to the state's Department of Health and Senior Services.

The big picture: The CDC reported 2,807 confirmed hospital cases of severe respiratory illnesses as of Feb. 18, among those who vaped nicotine or cannabis products in 50 states, D.C. and two U.S. territories.

  • The rate of reported cases each week has slowed considerably since August.

Go deeper:

Go deeper

2 hours ago - Health

Prior coronavirus infections may not protect well against Omicron

Illustration: Aïda Amer/Axios

New data from South Africa suggests the Omicron variant spreads more than twice as quickly as the Delta variant, and that immunity from prior infection doesn't appear to protect a person very well against Omicron variant.

Why it matters: The findings are extremely preliminary, and there are still many open questions about how well vaccines work against the variant. But these initial breadcrumbs of data are helping the world begin to understand what it's up against.

Bryan Walsh, author of Future
3 hours ago - Technology

AI could end foreign-language subtitles

Illustration: Shoshana Gordon/Axios

AI companies are developing methods to translate and synthesize voices in ads, movies and TV.

Why it matters: The advances in voice synthesis could help fix bad movie dubbing — and they come as international content is becoming increasingly important to studios and streaming platforms as part of the globalization of entertainment.

Bryan Walsh, author of Future
Updated 12 hours ago - Technology

A dark view of the future of autonomous weapons

A still from the video "If Human: Kill ( )." Image: Future of Life Institute

A new short film warns of the coming risks posed by the development and proliferation of lethal autonomous weapons.

Why it matters: Drones with the ability to autonomously target and kill without the assistance of a human operator are reportedly already being used on battlefields, and time is running out to craft a global ban of what could be a destabilizing and terrifying new class of weapon.

You’ve caught up. Now what?

Sign up for Mike Allen’s daily Axios AM and PM newsletters to get smarter, faster on the news that matters.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!